Avandia: A History of Controversy

Avandia was released by GlaxoSmithKline in 1999 and marketed as an exciting step forward in the field of diabetes-control – a drug which significantly reduced the risks associated with living with Type 2 diabetes. However, within ten years, controversy and a series of damaging studies took the drug from a staggering high to a stunning low.

If you or someone you love has experienced health problems as a result of taking the diabetes-control drug Avandia, you and your family may be entitled to financial compensation. To learn more about how the Avandia lawsuit attorneys of the firm may be able to help you and your family, please contact us today by calling the firm.

Controversial Findings

In 2006, Avandia was bringing GlaxoSmithKline some $2.5 billion in sales revenue a year. However, in 2007 an independent panel of experts released a report suggesting there may be a serious risk of heart attack and stroke associated with the drug. While the Food and Drug Administration (FDA) allowed the product to stay on the market, it required a warning to be placed on the box.

Senators Max Bacchus and Charles Grassley filed a report requesting that Avandia be removed from the market, and cited a report alleging that there were 500 heart attacks every month which were caused by the drug. By 2009, sales of the drug had fallen by 80% and GlaxoSmithKline was facing thousands of lawsuits related to Avandia.

Contact Us

If you or someone you love has experienced health problems as a result of being prescribed Avandia, you may be entitled to compensation. To learn more about what the Avandia attorneys of the firm may be able to do for you, please contact us today by calling the firm.